Skip to main content
Premium Trial:

Request an Annual Quote

Health Canada Clears Cepheid's MRSA Test to Combat Hospital Infections

NEW YORK (GenomeWeb News) – The Canadian government has licensed Cepheid’s test for methicillin-resistant Staphylococcus aureus for use in hospitals, the company said today.
 
The company said Health Canada’s device license for the Xpert MRSA test, which runs on the GeneXpert System and identifies MRSA in around 70 minutes, can help Canadian healthcare organizations maintain better control measures for MRSA hospital-acquired infections. 
 
A government committee in Ontario last year recommended that high-risk patients “should be actively screened for MRSA,” the company said. The rate of MRSA occurrence in Canadian hospitals has risen “steadily between 1995 and 2004,” Cepheid added in a statement.
 
“We expect to see more countries moving toward initiation of active surveillance programs," said Cepheid CEO John Bishop.
 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.